CDTI PiD 2018
BIOSFER TESLAB, SL supported by CDTI under the PID Programme is implementing the Development of a prediction test for cardiometabolic disease, based on the advanced molecular profile using Nuclear Magnetic Resonance (NMR) spectroscopy and machine learnig techniques.
CDTI Neotec 2017
BIOSFER TESLAB, SL supported by CDTI under the NEOTEC Operational Programme is implementing the Development of new in vitro test based on Nuclear Magnetic Resonance (NMR) spectroscopy for an early detection of cardiometabolic diseases and cardiovascular diseases.
Industrial Doctoral Plan Fellowship 2016
Funded project: 1H-NMR glycoprotein analysis. An Advanced approach for inflammatory diseases diagnosis.
Nuclis RD15-1-0013 2016
Biosfer Teslab, along the project, has developed a system of prediction, using of advanced prediction tests, with the aim to improve the evaluation of cardiovascular risk and to identify those individuals with residual cardiovascular risk that would remain undiagnosed with classical risk factors.
Enisa Funding 2015
Enisa is a public company – dependent to the Ministry of Industry, Energy and Tourism, via the General Directorate of Industries and small and medium-sized enterprises – that, since 1982, is also actively involved in the financing of innovative and viable business projects.
